Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Pejman
    Member
    • Jul 2010
    • 23

    #1

    Suspicious results from CuffDiff

    Hey folks
    I'm running CuffDiff from the release 0.9.2, for RNAseq. I use it with tophat, and Reference annotation for human data. Here's the simple running command:


    Code:
    cuffdiff --FDR 0.01 -N hg18_annotation01.gtf accepted_hits1.bam accepted_hits2.bam

    There are few points of concern

    first: over 90% of the genes with "status = OK" have "Significant = yes" which is kinda not so nice.

    second: that there are so many genes with very low FPKM that are among the significant ones, which can also lead to fold changes like: 1.7977e+308 !

    and third: There are genes with large FPKMs that have not been tested (status = NOTEST) , here's some sample, from the file "genes_expr.diff", with a "NOTEST gene with hight FPKM, and two low FPKM genes with test status "OK":


    Code:
    ttest_id	status	value_1	value_2	ln(fold_change)	test_stat	p_value	significant
    NR_036659	NOTEST	1119.85	6601.74	1.774 		-54.911 	0	no
    NM_001130440	OK	5.6E-09	5.7E-09	0.030 		-1.744 		0.081	no
    NM_001001977	OK	9.7E-09	1.2E-08	0.227	 	-18.416 	0	yes
    Does somebody have some idea? :-/

    thanks
    pej
  • Boel
    Member
    • Oct 2009
    • 62

    #2
    Hi Pejman,

    Any progress with the fact that so many of the genes with "status = OK" have "Significant = yes"? Kind of seeing the same thing.

    Boel

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...